GL-V9, an agonist of the small molecule adenosine 5′-monophosphate-activated protein kinase (AMPK), significantly degrades the NLRP3 inflammasome complex in macrophages by inducing autophagy, thereby preventing colitis (141). The gene discussed is NLRP3; the disease is colitis.